Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 34 for “"STK11"”.
-
The role of LKB1 (STK11) in non-small cell lung cancer
<p>LKB1 is the second most commonly altered tumour suppressor gene in lung adenocarcinoma, the most prevalent form of lung cancer. LKB1 is a "master kinase" that has been shown to phosphorylate up to 13 downstream targets. We hypothesised that LKB1 loss is associated with an increased dependency on …
-
Comprehensively Testing the Function of Missense Variation in the STK11 CHEK2 Tumour Suppressors
… kinase tumour suppressor proteins, STK11/LKB1 and CHEK2, approximately 87% and 95% of missense variants in ClinVar are classified as VUS respectively. This thesis details DMS experiments that tested protein function for almost all possible coding (covering approximately 90% of …
-
Exploring the immune signature of lung adenocarcinoma: examining RORγT expression in KRAS and STK11 mutant tumours
… 11 different key cancer genes including KRAS and STK11. Although both these groups had generally low immune gene expression, each demonstrated significantly increased RORC mRNA expression, which encodes the T helper 17 (Th17) transcription factor RORγT. Using a unique cohort of mutationally …
-
Tumor-Derived Complement C3 Overexpression in STK11-Mutant Lung Adenocarcinoma Drives Tumor Growth and Immune Evasion
Loss of function STK11-mutations occur in about 15-20% of lung adenocarcinoma (LUAD) and are associated with aggressive tumor growth, poor survival and immunotherapy failure. STK11 encodes LKB1, which regulates multiple key elements of cellular growth and metabolism. However, the biological …
-
Integrated Molecular Characterization of Lung Adenocarcinoma with Implications for Immunotherapy
… of lung adenocarcinoma with an emphasis on STK11 loss and its implications on immunotherapy response. Given that lung cancer is the leading cancer killer, novel therapies are in great demand. In particular, immunotherapy has shown some of the most promise in the last decade but remains …
-
AXL Targeting Restores PD-1 Blockade Sensitivity of STK11/LKB1 Mutant NSCLC Through Expansion of TCF1+ CD8 T Cells
Mutations in STK11/LKB1 in non-small cell lung cancer (NSCLC) are associated with poor patient responses to immune checkpoint blockade (ICB) for unknown reasons. We found that introduction of a Stk11/Lkb1 (L) mutation into murine lung adenocarcinomas driven by mutant Kras and Trp53 (KP) resulted in …
-
Functional Genomics Based Interrogation of Cell-Fate Determination Pathways
… in both pathways for the multitasking kinase Stk11 (also known as Lkb1), a tumor suppressor implicated in lung and cervical cancers. Stk11 loss resulted in disassembly of the primary cilium, a cellular organizing center for Hh pathway components, thus dampening Hh signaling. Loss of Stk11 also …
-
The association between common genetic variation in STK11 (LKB1) and colorectal adenomas in the Health Professional's Follow-up Study and the Nurses' Health Study
… mutations in serine-threonine kinase 11 (<ITALIC>STK11</ITALIC>) are hallmarks in hamartomatous polyps of the rare, hereditary disease, Peutz-Jeghers syndrome (PJS). PJS is associated with colorectal hamartomatous polyps and results in an increased risk of colorectal cancer and other malignancies. …
-
Mechanisms and Molecular Biology of Major Tumor Suppressors
… the major tumor suppressors pRb and STK11 are explored in the context of osteosarcoma and lung cancer, respectively. RB1 was the first tumor suppressor gene discovered. Over four decades of work have revealed that the Rb protein (pRb) is a master regulator of biological pathways …
-
The Genomic Landscape and Prognostic Impact of KRAS, STK11, and SMARCA4 Mutations and Co-Mutations on Survival Outcomes in Non-Small Cell Lung Cancer
… homolog (KRAS), Serine/Threonine Kinase 11 (STK11), and SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily A, member 4 (SMARCA4) mutations and co-mutations have been increasingly recognized for their potential prognostic significance. However, clear …
-
THE ROLE OF LKB1 AND PTEN IN THE DEVELOPMENT OF PAPILLARY SEROUS OVARIAN CANCER
… Tumor suppressor genes upstream of mTORC1, STK11, PTEN, and TSC2, are deleted in 88%, 40%, and 55% of high grade serous ovarian cancer, respectively. In deleting these genes alone and in combinations in the ovarian surface epithelium of mice, we found that papillary serous ovarian cancer …
-
The identification of novel therapy options in difficult to treat non-small cell Lung cancer
… common subsets of smoking related lung cancer: STK11-mutant lung adenocarcinoma, KRAS-mutant lung adenocarcinoma and 3q amplified squamous cell lung cancer. In STK11-mutant lung cancer, this thesis seeks to explore resistance to mTORC1/2 inhibition. In KRAS-mutant lung cancer, this thesis seeks …
-
The effects of metformin on immune cell function in prediabetic patients
… candidates, SLC2A4, LIPE, INSR, CRY1, GAPDH, and STK11 had the greatest log2 fold change and –log (p-value). Further analysis on the 4 subjects compared delta Ct values and relative gene expression showing CRY1, a circadian function gene, had a significant decrease in expression (p=0.03, n=4, …
-
Glutamine metabolism in cancer : a double-edged sword in cancer therapy and immune modulation
… normal tissue, and from biomarkers such as STK11/LKB1 and KEAP1 mutation status, which mark tumors with heightened glutamine dependence, and identify patients most likely to benefit.
-
Κοινά μοριακά μονοπάτια παθογένεσης καρκίνου μαστού και αναπαραγωγικού συστήματος θήλεος
… BRCA2, p53, ΡΤΕΝ, CHEK2, CDH1, MSH2/6, ATM, STK11, RAD50, BRIP1 και PALB2. Οι μηχανισμοί καρκινογένεσης του μαστού λόγω της πολυπλοκότητας τους δεν είναι πλήρως αποσαφηνισμένοι. Στην ογκογένεση του μαστού εμπλέκονται πολλά σηματοδοτικά μονοπάτια, τα οποία υπό φυσιολογικές συνθήκες είναι …
-
Pathology of familial and hereditary breast cancer : differences between breast cancer mutation carriers, types and management. A literature review.
… PTEN, CDH1, MSH1, MLH1, MSH6, PMS2, PALB2 και STK11), και γονίδια μέτριας διείσδυσης (CHEK2, ATM , BRIP1), σχετίζονται επίσης με υψηλό δια βίου κίνδυνο για καρκίνο του μαστού και άλλων κακοηθειών. Γονίδια χαμηλής διείσδυσης έχουν αναγνωριστεί και αυξάνουν τον κίνδυνο ανάπτυξης καρκίνου του …
-
Investigating Novel Targets to Inhibit Cancer Cell Survival
… regulating protein serine-threonine kinase 11 (STK11). Because of the unique role that Linc00467 serves in regulating autophagy we renamed it as, autophagy regulating long intergenic noncoding RNA or ARLINC. Taken together the work in this dissertation unveils the inner-workings of two important …
-
Multimodale Marker des Lungenkarzinoms zur Erfassung von Therapieresistenz und Tumorprogression
… Ko-Mutationen in den Genen KRAS, KEAP1 und STK11 ein um 32% verringertes Überleben beobachtet. Als radiologi-sche Biomarker identifizierten wir vor allem das CT-Texturmerkmal 'Sum of Entropy' als einen vielversprechender radiologischen Parameter, der zu einen bei der Unterscheidung zwischen …
Page 1 of 2